<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="/stylesheet.xsl" type="text/xsl"?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:sy="http://purl.org/rss/1.0/modules/syndication/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:podcast="https://podcastindex.org/namespace/1.0">
  <channel>
    <atom:link rel="self" type="application/rss+xml" href="https://feeds.transistor.fm/spherofill-insights" title="MP3 Audio"/>
    <atom:link rel="hub" href="https://pubsubhubbub.appspot.com/"/>
    <podcast:podping usesPodping="true"/>
    <title>SpheroFill Insights</title>
    <generator>Transistor (https://transistor.fm)</generator>
    <itunes:new-feed-url>https://feeds.transistor.fm/spherofill-insights</itunes:new-feed-url>
    <description>Spherofill Insights is a science-focused podcast series exploring the challenges of modern pharmaceutical drug delivery and the potential of emerging technologies to address them. Through engaging conversations between a physician-innovator and a pharmaceutical formulation scientist, each episode examines current peer-reviewed research, existing treatment and formulation strategies, and important unmet needs in drug development.

The series focuses on the potential of SpheroFill's porous-wall hollow glass microsphere (PWHGM) technology to offer innovative approaches to drug loading, protection, targeting, and controlled release. Beginning with oral drug delivery and expanding into applications such as implantable drug depots, localized therapies, and tissue repair, the series combines scientific curiosity with thoughtful, evidence-based analysis—celebrating promising innovations while openly examining their limitations and unanswered questions.

The goal is not simply to promote a technology, but to make complex pharmaceutical science accessible, spark meaningful scientific discussion, and explore what's possible. 

SpheroFill Insights makes use of AI-generated voiceover technology from JellyPod.</description>
    <copyright>2026 SpheroFill Holding SC LLC</copyright>
    <podcast:guid>d9b4a400-a130-5d6e-9f26-00eee19bed52</podcast:guid>
    <podcast:locked>yes</podcast:locked>
    <language>en</language>
    <pubDate>Wed, 28 Oct 2026 00:25:09 -0500</pubDate>
    <lastBuildDate>Wed, 28 Oct 2026 00:26:06 -0500</lastBuildDate>
    <link>https://spherofill.net</link>
    <image>
      <url>https://img.transistorcdn.com/UELcz3FBGwrhNh15GHcntOfPP5uF5Wm0hFC2qPfxrok/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9mZmNj/MTA2ZjU2YmEzYmM0/MzI5OWY5MmRlNzY2/ZmJiNy5wbmc.jpg</url>
      <title>SpheroFill Insights</title>
      <link>https://spherofill.net</link>
    </image>
    <itunes:category text="Science">
      <itunes:category text="Chemistry"/>
    </itunes:category>
    <itunes:type>serial</itunes:type>
    <itunes:author>SpheroFill</itunes:author>
    <itunes:image href="https://img.transistorcdn.com/UELcz3FBGwrhNh15GHcntOfPP5uF5Wm0hFC2qPfxrok/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9mZmNj/MTA2ZjU2YmEzYmM0/MzI5OWY5MmRlNzY2/ZmJiNy5wbmc.jpg"/>
    <itunes:summary>Spherofill Insights is a science-focused podcast series exploring the challenges of modern pharmaceutical drug delivery and the potential of emerging technologies to address them. Through engaging conversations between a physician-innovator and a pharmaceutical formulation scientist, each episode examines current peer-reviewed research, existing treatment and formulation strategies, and important unmet needs in drug development.

The series focuses on the potential of SpheroFill's porous-wall hollow glass microsphere (PWHGM) technology to offer innovative approaches to drug loading, protection, targeting, and controlled release. Beginning with oral drug delivery and expanding into applications such as implantable drug depots, localized therapies, and tissue repair, the series combines scientific curiosity with thoughtful, evidence-based analysis—celebrating promising innovations while openly examining their limitations and unanswered questions.

The goal is not simply to promote a technology, but to make complex pharmaceutical science accessible, spark meaningful scientific discussion, and explore what's possible. 

SpheroFill Insights makes use of AI-generated voiceover technology from JellyPod.</itunes:summary>
    <itunes:subtitle>Spherofill Insights is a science-focused podcast series exploring the challenges of modern pharmaceutical drug delivery and the potential of emerging technologies to address them.</itunes:subtitle>
    <itunes:keywords>PWHGM, drug delivery, mesoporous, biotech, startup</itunes:keywords>
    <itunes:owner>
      <itunes:name>Paul Weinberger</itunes:name>
    </itunes:owner>
    <itunes:complete>No</itunes:complete>
    <itunes:explicit>No</itunes:explicit>
    <item>
      <title>Tiny Bubbles, Big Possibilities: Introducing Porous-Wall Hollow Glass Microspheres</title>
      <itunes:episode>1</itunes:episode>
      <podcast:episode>1</podcast:episode>
      <itunes:title>Tiny Bubbles, Big Possibilities: Introducing Porous-Wall Hollow Glass Microspheres</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">323e4b08-9c7f-4e85-aa5f-9872ff381aca</guid>
      <link>https://share.transistor.fm/s/bdd7e290</link>
      <description>
        <![CDATA[<p>What if tiny glass bubbles originally developed for homeland defense purposes could help solve some of the biggest challenges in modern medicine? In this inaugural episode of SpheroFill Insights, discover the remarkable science behind porous-wall hollow glass microspheres (PWHGMs)—microscopic silica containers with hollow interiors and nanoscale channels that open intriguing possibilities for pharmaceutical drug delivery. From protecting fragile medicines and controlling drug release to targeting specific tissues and potentially enabling personalized, multi-drug therapies, explore how an ingenious piece of materials engineering could inspire new approaches to delivering tomorrow's medicines.</p><p>SpheroFill Insights makes use of AI-generated voiceover technology from JellyPod.</p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>What if tiny glass bubbles originally developed for homeland defense purposes could help solve some of the biggest challenges in modern medicine? In this inaugural episode of SpheroFill Insights, discover the remarkable science behind porous-wall hollow glass microspheres (PWHGMs)—microscopic silica containers with hollow interiors and nanoscale channels that open intriguing possibilities for pharmaceutical drug delivery. From protecting fragile medicines and controlling drug release to targeting specific tissues and potentially enabling personalized, multi-drug therapies, explore how an ingenious piece of materials engineering could inspire new approaches to delivering tomorrow's medicines.</p><p>SpheroFill Insights makes use of AI-generated voiceover technology from JellyPod.</p>]]>
      </content:encoded>
      <pubDate>Tue, 27 Oct 2026 10:39:55 -0500</pubDate>
      <author>SpheroFill</author>
      <enclosure url="https://media.transistor.fm/bdd7e290/9e1aa71c.mp3" length="14475870" type="audio/mpeg"/>
      <itunes:author>SpheroFill</itunes:author>
      <itunes:duration>901</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>What if tiny glass bubbles originally developed for homeland defense purposes could help solve some of the biggest challenges in modern medicine? In this inaugural episode of SpheroFill Insights, discover the remarkable science behind porous-wall hollow glass microspheres (PWHGMs)—microscopic silica containers with hollow interiors and nanoscale channels that open intriguing possibilities for pharmaceutical drug delivery. From protecting fragile medicines and controlling drug release to targeting specific tissues and potentially enabling personalized, multi-drug therapies, explore how an ingenious piece of materials engineering could inspire new approaches to delivering tomorrow's medicines.</p><p>SpheroFill Insights makes use of AI-generated voiceover technology from JellyPod.</p>]]>
      </itunes:summary>
      <itunes:keywords>PWHGM, drug delivery, mesoporous, biotech, startup</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>Mesoporous Silica versus SpheroFill PWHGMs</title>
      <itunes:episode>2</itunes:episode>
      <podcast:episode>2</podcast:episode>
      <itunes:title>Mesoporous Silica versus SpheroFill PWHGMs</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">0baecc92-4ff0-4a3e-a44c-8ad714230269</guid>
      <link>https://share.transistor.fm/s/38b7ba40</link>
      <description>
        <![CDATA[<p>It may surprise you to learn that silica glass is already widely used in foods and pharmaceuticals, but what happens when scientists engineer it to carry medicine? Explore the fascinating differences between conventional mesoporous silica “sponges” and SpheroFill’s porous-wall hollow glass microspheres (PWHGMs). Discover how a fundamentally different particle architecture creates new possibilities for drug loading, protection, and controlled release—and why these two technologies might someday work even better together.  SpheroFill Insights makes use of AI-generated voiceover technology from JellyPod.</p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>It may surprise you to learn that silica glass is already widely used in foods and pharmaceuticals, but what happens when scientists engineer it to carry medicine? Explore the fascinating differences between conventional mesoporous silica “sponges” and SpheroFill’s porous-wall hollow glass microspheres (PWHGMs). Discover how a fundamentally different particle architecture creates new possibilities for drug loading, protection, and controlled release—and why these two technologies might someday work even better together.  SpheroFill Insights makes use of AI-generated voiceover technology from JellyPod.</p>]]>
      </content:encoded>
      <pubDate>Tue, 27 Oct 2026 12:01:32 -0500</pubDate>
      <author>SpheroFill</author>
      <enclosure url="https://media.transistor.fm/38b7ba40/68c5b984.mp3" length="12137270" type="audio/mpeg"/>
      <itunes:author>SpheroFill</itunes:author>
      <itunes:duration>755</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>It may surprise you to learn that silica glass is already widely used in foods and pharmaceuticals, but what happens when scientists engineer it to carry medicine? Explore the fascinating differences between conventional mesoporous silica “sponges” and SpheroFill’s porous-wall hollow glass microspheres (PWHGMs). Discover how a fundamentally different particle architecture creates new possibilities for drug loading, protection, and controlled release—and why these two technologies might someday work even better together.  SpheroFill Insights makes use of AI-generated voiceover technology from JellyPod.</p>]]>
      </itunes:summary>
      <itunes:keywords>PWHGM, drug delivery, mesoporous, biotech, startup</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
  </channel>
</rss>
